A
Alcista
Alcista · 25%BGM
$14.82
Precio del escenario
$9.000
-0.509 (-5.66%)Al cierre
Loading chart…
- Máximo
- 9.560
- Apertura
- 7.950
- Precio medio ponderado por volumen
- 8.84
- Volumen
- 29.39K
- Capitalización
- —
- Mínimo
- 7.950
- Importe
- 259.67K
- EV/EBITDA, TTM
- 0.00
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Análisis de IA of BGM Group Ltd (BGM)
ComprarBGM Group Ltd is a good buy right now due to its recent 5-day price increase of 13.57%, indicating positive short-term momentum, and a current RSI of 63.755, suggesting it is nearing overbought territory but still has room to grow. The stock is currently priced at 9.54, significantly below its 52-week high of 302.40, which presents a substantial upside potential. However, investors should be cautious of the negative catalyst of a year-to-date change of -91.12%, indicating a long-term downtrend that could affect future performance.
Métricas de valoración
El PER previsto actual de BGM Group Ltd (BGM) es 0.00, frente a su media de 5 años de 0.00.
Escenarios de precio de Alphio AI para BGM
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
2.012-17BenzingaToro, DBV Technologies, Udemy, ABM Industries, and Other Major Stocks Rising on Wednesday
2.009-24BenzingaMajor Stocks Including Freeport-McMoRan, Harmony Biosciences, and Cohu Decline on Wednesday
2.009-17BenzingaMajor Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday
9.507-23PRnewswireBGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
8.505-28NewsfilterFrom Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
Preguntas frecuentes sobre BGM, respondidas por Alphio AI
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market. It operates in the Healthcare sector.
BGM Group Ltd is a good buy right now due to its recent 5-day price increase of 13.57%, indicating positive short-term momentum, and a current RSI of 63.755, suggesting it is nearing overbought territory but still has room to grow. The stock is currently priced at 9.54, significantly below its 52-week high of 302.40, which presents a substantial upside potential. However, investors should be cautious of the negative catalyst of a year-to-date change of -91.12%, indicating a long-term downtrend that could affect future performance.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.